Study improves lethal brain cancer diagnosis.

In Brain Cancer, Brain Science by Brainy Days Ahead

A new study conducted by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute concludes that taking molecular variables into account will improve the prognostic classification of the lethal brain cancer called glioblastoma (GBM).